P3 Health Partners Inc. (PIII) — Financial statements
Income statement, balance sheet, and cash flow for P3 Health Partners Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,459↓2.8% | 1,500↑18.5% | 1,266↑20.7% | 1,049↑64.7% | 637 | |
| Cost of Revenue | 1,603 | 0.00 | 0.00 | 0.00↓100.0% | 668 | |
| Gross Profit | -144↓109.6% | 1,500↑18.5% | 1,266↑20.7% | 1,049↑3518.3% | -31 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 106↓5.6% | 113↓8.0% | 122↓22.2% | 157 | 0.00 | |
| Selling & Marketing Expenses | 0.92↓31.0% | 1↓58.8% | 3↓36.6% | 5 | 0.00 | |
| SG&A Expenses | 107↓5.9% | 114↓9.3% | 126↓22.7% | 162↑3.3% | 157 | |
| Other Expenses | 19↓98.9% | 1,707↑30.4% | 1,309↓46.5% | 2,448 | 0.00 | |
| Operating Expenses | 126↓93.1% | 1,821↑27.0% | 1,434↓45.1% | 2,610↑1560.1% | 157 | |
| Total Costs & Expenses | 1,729↓5.0% | 1,821↑27.0% | 1,434↓45.1% | 2,610↑216.3% | 825 | |
| Operating Results | ||||||
| Operating Income | -270↑15.7% | -321↓90.9% | -168↑89.2% | -1,561↓730.5% | -188 | |
| Depreciation & Amortization | 84↓2.2% | 86↓0.7% | 87↓0.7% | 87↑900.6% | 9 | |
| EBITDA | -186↑5.9% | -198↓143.9% | -81↑94.5% | -1,461↓691.4% | -185 | |
| EBIT | -270↑4.8% | -284↓69.2% | -168↑89.2% | -1,548↓700.8% | -193 | |
| Interest & Other Income | ||||||
| Net Interest Income | -55↓148.2% | -22↓38.7% | -16↓40.2% | -11↓6.8% | -11 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 55↑148.2% | 22↑38.7% | 16↑40.2% | 11↑6.8% | 11 | |
| Non-Operating Income | 0.00↑100.0% | -37↓19921.7% | -0.18↑98.5% | -13↓334.0% | 5 | |
| Other Income / Expenses | -51↓868.0% | 7↑141.8% | -16↓1397.3% | 1↑107.4% | -16 | |
| Income Before Tax | -321↓4.9% | -306↓66.5% | -184↑88.2% | -1,560↓663.3% | -204 | |
| Income Tax Expense | 2↓53.8% | 4↑62.8% | 3↑44.7% | 2 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -323↓4.1% | -310↓66.5% | -186↑88.1% | -1,562↓664.2% | -204 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -148↓8.9% | -136↓135.1% | -58↑78.6% | -270↓72.6% | -156 | |
| Bottom-Line Net Income | -148↑6.9% | -159↓175.1% | -58↑78.6% | -270↓72.6% | -156 | |
| EPS (Basic) | -45.26↑3.3% | -46.79↓53.7% | -30.44↑90.6% | -324.84↓72.6% | -188.17 | |
| EPS (Diluted) | -45.26↑16.3% | -54.06↓77.6% | -30.44↑90.6% | -324.84↓72.6% | -188.17 | |
| Weighted Average Shares | 3↑12.6% | 3↑53.0% | 2↑128.2% | 0.83↑0.0% | 0.83 | |
| Weighted Average Diluted Shares | 3↑11.2% | 3↑54.9% | 2↑128.2% | 0.83↑0.0% | 0.83 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.